Natixis Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$25.8M Buy
78,016
+33,681
+76% +$11.5M 0.04% 421
2025
Q4
$17.6M Buy
44,335
+22,653
+104% +$10M 0.03% 523
2025
Q3
$9.89M Buy
21,682
+11,573
+114% +$4.71M 0.01% 662
2025
Q2
$3.3M Buy
+10,109
New +$2.8M 0.01% 938
2025
Q1
Sell
-10,453
Closed -$2.46M 1603
2024
Q4
$2.46M Buy
10,453
+451
+5% +$119K ﹤0.01% 1030
2024
Q3
$2.75M Buy
+10,002
New +$2.6M 0.01% 987
2022
Q2
Sell
-10,359
Closed -$1.69M 1455
2022
Q1
$1.69M Sell
10,359
-2,164
-17% -$330K 0.01% 1004
2021
Q4
$2.12M Sell
12,523
-7,329
-37% -$1.36M 0.01% 927
2021
Q3
$3.75M Buy
19,852
+8,461
+74% +$1.59M 0.02% 735
2021
Q2
$1.93M Buy
+11,391
New +$1.67M 0.01% 920

Other funds holding ALNY